As GLP-1 medications like Ozempic and Wegovy gain popularity for weight management, conversations around their use are becoming increasingly complex. Rapid or noticeable weight loss often sparks questions from friends, colleagues, and acquaintances, but experts caution that how and why such questions are asked matters.
Dr. Whitney Casares, a pediatrician in Portland, recalls being asked point-blank by an acquaintance if she was taking Ozempic. “It felt terrible because it wasn’t someone I was close with,” she said. “They weren’t sharing anything about themselves; they just wanted details about me.” Casares advises that anyone considering asking should first reflect on their motives. “Are you curious because you want to try it yourself, or is it just nosiness?” she said.
Psychologist Rachel Goldman, a clinical assistant professor at NYU Grossman School of Medicine, agrees that intentions are key. She said that asking about GLP-1 medications is acceptable if the goal is to learn for personal decision-making. “If you’re asking because you’re just curious, you don’t need to know,” she said.
Experts emphasize that the phrasing of the question is critical. Approaching the conversation with compassion, respect, and transparency helps create a safe space. Goldman suggests framing questions in a non-assuming way, such as: “I’ve noticed you’ve been making healthier choices. I’ve been thinking about starting a GLP-1, and I’m wondering if you’ve considered it.” This gives the person the option to decline without feeling pressured.
For those already on GLP-1 medications, Goldman advises showing vulnerability first. A conversation could begin with, “I’ve been struggling with my weight. Would you be open to a conversation about your experience?” Casares stresses that such discussions should remain private to avoid making someone feel cornered or judged. Tone and curiosity, rather than judgment, are essential.
People using GLP-1 drugs can also manage questions strategically. Casares has chosen to be upfront about her experience. When greeted with comments like, “Wow, you look great!” she responds honestly: “Yeah, I’ve been taking a GLP-1, and it’s going so well.” If the other person shows interest, she shares her experience further, but emphasizes that no one is obliged to disclose private health information.
For those wishing to avoid the topic, Goldman suggests responses that are truthful yet protective of privacy: “I’m making healthier choices. I’m going to the gym. I’m being mindful of what I’m eating or working with a health care professional.”
As GLP-1 medications reshape conversations about weight and health, experts encourage respect, self-reflection, and thoughtful communication. The goal is to navigate these discussions without judgment while preserving personal boundaries and dignity.
